Evidence map›Paper›PMID 32393506›Full record

ArticleInfection and immunity2020

Progress towards the Development of a NEAT Vaccine for Anthrax II: Immunogen Specificity and Alum Effectiveness in an Inhalational Model.

Joseph Jelinski, Austen Terwilliger, Sabrina Green, Anthony Maresso

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Anthrax: A narrative review.New microbes and new infections · 2024
    Review
  3. Article
  4. Review
  5. Article
  6. Biodefence research two decades on: worth the investment?The Lancet. Infectious diseases · 2021
    Review
  7. Article
  8. TheMicroorganisms · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Joseph JelinskiDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Austen TerwilligerDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Sabrina GreenDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Anthony MaressoDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA maresso@bcm.edu.
Baylor College of Medicine · US

Funding

Nutrient Uptake during Anthrax DiseaseR01AI097167 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI MARESSO, ANTHONY W · 2012 to 2022
$3.5M
The Importance and Function of Heme Degrading Enzymes during Anthrax DiseaseR21AI125778 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI MARESSO, ANTHONY W · 2017 to 2018
$436k
Next-stage Development of Heme Transporters as a Vaccine for AnthraxR21AI133001 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI MARESSO, ANTHONY W · 2017 to 2018
$436k
NIAID NIH HHS R01 AI097167NIAID NIH HHS R21 AI125778NIAID NIH HHS R21 AI133001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, InhalationAlum CompoundsAnimalsAnthraxAnthrax VaccinesAntibodies, BacterialAntibodies, NeutralizingAntigens, BacterialBacillus anthracisBacterial ProteinsCarrier ProteinsComplement C5FemaleFreund's AdjuvantHumansImmunogenicity, VaccineAlum Compoundsaluminum sulfateAnthrax VaccinesAntibodies, BacterialAntibodies, NeutralizingAntigens, BacterialBacterial ProteinsCarrier ProteinsComplement C5Freund's AdjuvantanthraxBacillusNEAT domainnutritional immunityvaccine

Identifiers

PMID32393506
PMCPMC7375772
OpenAlexW3023891383

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.